Purdue Pharma agrees $12bn settlement in opioids case, plaintiffs’ lawyers say

  • Offer by company and Sackler family valued at up to $12bn
  • Company to fight opponents of deal in bankruptcy proceedings

Purdue Pharma, the maker of OxyContin, has reached a tentative deal with about half the states and thousands of local governments over its role in America’s deadly opioid epidemic, but criticism by several state attorneys general clouded prospects for an end to litigation against the company and the family that owns it.

Arizona attorney general Mark Brnovich said the agreement included more money from the Sackler family, which had become a sticking point during the recent talks.

Continue reading…